triamterene has been researched along with Lung Neoplasms in 3 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triamterene was found to inhibit HDACs." | 1.91 | Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment. ( Cheung, KM; Cho, WCS; To, KKW, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| To, KKW | 1 |
| Cheung, KM | 1 |
| Cho, WCS | 1 |
| Alonso, DF | 1 |
| Farías, EF | 1 |
| Ladeda, V | 1 |
| Davel, L | 1 |
| Puricelli, L | 1 |
| Bal de Kier Joffé, E | 1 |
| Roberts, D | 1 |
| Hall, TC | 1 |
3 other studies available for triamterene and Lung Neoplasms
| Article | Year |
|---|---|
Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Repositioni | 2023 |
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.
Topics: Amidines; Amiloride; Animals; Antineoplastic Agents; Cell Division; Diuretics; Enzyme Inhibitors; Fe | 1996 |
Triamterene-induced elevation of dihydrofolate reductase activity in human leukocytes.
Topics: Carcinoma; Carcinoma, Squamous Cell; Enzyme Induction; Head and Neck Neoplasms; Humans; Leukocytes; | 1968 |